{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:19:23Z","timestamp":1786979963346,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T00:00:00Z","timestamp":1454976000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00296-016-3433-3","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T01:27:05Z","timestamp":1454981225000},"page":"751-758","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Reliable and cost-effective serodiagnosis of rheumatoid arthritis"],"prefix":"10.1007","volume":"36","author":[{"given":"Pieter W. A.","family":"Meyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood M. T. M.","family":"Ally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,9]]},"reference":[{"key":"3433_CR1","unstructured":"Ifad (2011) Rural poverty report 2011 [Electronic Report] Rome, Italy. www.ifad.org [cited 2015 13 July]. http:\/\/www.ifad.org\/rpr2011\/report\/e\/overview.pdf"},{"issue":"5","key":"3433_CR2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0049-0172(00)80017-7","volume":"29","author":"KM Pugner","year":"2000","unstructured":"Pugner KM, Scott DI, Holmes JW, Hieke K (2000) The costs of rheumatoid arthritis: an international long-term view. Semin Arthritis Rheum 29(5):305\u2013320","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"3433_CR3","first-page":"161","volume":"2","author":"H Behzad","year":"2011","unstructured":"Behzad H (2011) Rheumatoid arthritis: early diagnosis and treatment outcomes. Casp J Intern Med 2(1):161\u2013170","journal-title":"Casp J Intern Med"},{"issue":"1","key":"3433_CR4","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1186\/ar4491","volume":"16","author":"H Radner","year":"2014","unstructured":"Radner H, Smolen JS, Aletaha D (2014) Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs. Arthritis Res Ther 16(1):R56","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3433_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","volume":"75","author":"PWA Smolen","year":"2016","unstructured":"Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P et al (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 75(1):3\u201315","journal-title":"Ann Rheum Dis"},{"key":"3433_CR6","doi-asserted-by":"crossref","unstructured":"Meyer PWA, Hodkinson B, Mahmood A, Musenge E, Wadee AA, Fickl H et al (2010) Circulating cytokine profiles and their relationship with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis. Mediat Inflamm, Article ID 158154. doi: 10.1155\/2010\/158514","DOI":"10.1155\/2010\/158514"},{"issue":"5","key":"3433_CR7","doi-asserted-by":"crossref","first-page":"R160","DOI":"10.1186\/ar3479","volume":"13","author":"PW Meyer","year":"2011","unstructured":"Meyer PW, Hodkinson B, Ally M, Musenge E, Wadee AA, Fickl H et al (2011) HLA-DRB1 shared epitope genotyping using the revised classification and its association with circulating autoantibodies, acute phase reactants, cytokines and clinical indices of disease activity in a cohort of South African rheumatoid arthritis patients. Arthritis Res Ther 13(5):R160","journal-title":"Arthritis Res Ther"},{"key":"3433_CR8","first-page":"183653","volume":"2013","author":"MM Ally","year":"2013","unstructured":"Ally MM, Hodkinson B, Meyer PW, Musenge E, Tikly M, Anderson R (2013) Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis. Mediat Inflamm 2013:183653","journal-title":"Mediat Inflamm"},{"issue":"1","key":"3433_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2164-14-1","volume":"14","author":"A May","year":"2013","unstructured":"May A, Hazelhurst S, Li Y, Norris SA, Govind N, Tikly M et al (2013) Genetic diversity in black South Africans from Soweto. BMC Genom 14(1):1\u201312","journal-title":"BMC Genom"},{"issue":"1","key":"3433_CR10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2119\/molmed.2014.00097","volume":"20","author":"N Govind","year":"2014","unstructured":"Govind N, Choudhury A, Hodkinson B, Ickinger C, Frost J, Lee A et al (2014) Immunochip identifies novel, and replicates known, genetic risk loci for rheumatoid arthritis in Black South Africans. Mol Med 20(1):341\u2013349","journal-title":"Mol Med"},{"key":"3433_CR11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12891-015-0587-1","volume":"16","author":"MM Ally","year":"2015","unstructured":"Ally MM, Hodkinson B, Meyer PW, Musenge E, Tintinger GR, Tikly M et al (2015) Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. BMC Musculoskelet Disord 16:130","journal-title":"BMC Musculoskelet Disord"},{"issue":"5","key":"3433_CR12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11926-009-0053-x","volume":"11","author":"J Nam","year":"2009","unstructured":"Nam J, Villeneuve E, Emery P (2009) The role of biomarkers in the management of patients with rheumatoid arthritis. Curr Rheumatol Rep 11(5):371\u2013377","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"3433_CR13","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/acr.21767","volume":"64","author":"JR Curtis","year":"2012","unstructured":"Curtis JR, Van Der Helm-Van Mil AH, Knevel R, Huizinga TW, Haney DJ, Shen Y et al (2012) Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity. Arthritis Care Res 64(12):1794\u20131803","journal-title":"Arthritis Care Res"},{"issue":"2","key":"3433_CR14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.autrev.2012.05.007","volume":"12","author":"LA Trouw","year":"2012","unstructured":"Trouw LA, Mahler M (2012) Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis. Autoimmun Rev 12(2):318\u2013322","journal-title":"Autoimmun Rev"},{"issue":"4","key":"3433_CR15","doi-asserted-by":"crossref","first-page":"e60635","DOI":"10.1371\/journal.pone.0060635","volume":"8","author":"M Centola","year":"2013","unstructured":"Centola M, Cavet G, Shen Y, Ramanujan S, Knowlton N, Swan KA et al (2013) Development of a multi-biomarker disease activity test for rheumatoid arthritis. PLoS ONE 8(4):e60635","journal-title":"PLoS ONE"},{"key":"3433_CR16","first-page":"24","volume":"2014","author":"A Burska","year":"2014","unstructured":"Burska A, Boissinot M, Ponchel F (2014) Cytokines as biomarkers in rheumatoid arthritis. Mediat Inflamm 2014:24","journal-title":"Mediat Inflamm"},{"issue":"9","key":"3433_CR17","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/rheumatology\/kev023","volume":"54","author":"K Michaud","year":"2015","unstructured":"Michaud K, Strand V, Shadick NA, Degtiar I, Ford K, Michalopoulos SN et al (2015) Outcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis. Rheumatology (Oxford) 54(9):1640\u20131649","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3433_CR18","doi-asserted-by":"crossref","first-page":"020406","DOI":"10.7189\/jogh.02.020406","volume":"2","author":"B Dowman","year":"2012","unstructured":"Dowman B, Campbell RM, Zgaga L, Adeloye D, Chan KY (2012) Estimating the burden of rheumatoid arthritis in Africa: a systematic analysis. J Glob Health 2(2):020406","journal-title":"J Glob Health"},{"issue":"5","key":"3433_CR19","first-page":"204","volume":"86","author":"BO Owino","year":"2009","unstructured":"Owino BO, Oyoo GO, Otieno CF (2009) Socio-demographic and clinical aspects of rheumatoid arthritis. East Afr Med J 86(5):204\u2013211","journal-title":"East Afr Med J"},{"key":"3433_CR20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2474-11-2","volume":"11","author":"R Parker","year":"2010","unstructured":"Parker R, Jelsma J (2010) The prevalence and functional impact of musculoskeletal conditions amongst clients of a primary health care facility in an under-resourced area of Cape Town. BMC Musculoskelet Disord 11:2","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"3433_CR21","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/ar2945","volume":"12","author":"M Singwe-Ngandeu","year":"2010","unstructured":"Singwe-Ngandeu M, Finckh A, Bas S, Tiercy JM, Gabay C (2010) Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients. Arthritis Res Ther 12(2):R36","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"3433_CR22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10067-010-1374-x","volume":"29","author":"B Hodkinson","year":"2010","unstructured":"Hodkinson B, Meyer PW, Musenge E, Ally MM, Wadee AA, Anderson R et al (2010) The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis. Clin Rheumatol 29(6):615\u2013618","journal-title":"Clin Rheumatol"},{"key":"3433_CR23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10067-011-1900-5","volume":"31","author":"B Hodkinson","year":"2011","unstructured":"Hodkinson B, Musenge E, Ally M, Meyer PW, Anderson R, Tikly M (2011) Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritis. Clin Rheumatol 31:613\u2013619","journal-title":"Clin Rheumatol"},{"issue":"2","key":"3433_CR24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cyto.2012.06.190","volume":"60","author":"B Hodkinson","year":"2012","unstructured":"Hodkinson B, Meyer PW, Musenge E, Ally M, Anderson R, Tikly M (2012) Exaggerated circulating Th-1 cytokine response in early rheumatoid arthritis patients with nodules. Cytokine 60(2):561\u2013564","journal-title":"Cytokine"},{"issue":"4","key":"3433_CR25","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/art.20989","volume":"52","author":"S Tezenas Du Montcel","year":"2005","unstructured":"Tezenas Du Montcel S, Michou L, Petit-Teixeira E, Osorio J, Lemaire I, Lasbleiz S et al (2005) New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility. Arthritis Rheum 52(4):1063\u20131068","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3433_CR26","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3433_CR27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/08916930400022574","volume":"38","author":"Y Renaudineau","year":"2005","unstructured":"Renaudineau Y, Jamin C, Saraux A, Youinou P (2005) Rheumatoid factor on a daily basis. Autoimmunity 38(1):11\u201316","journal-title":"Autoimmunity"},{"key":"3433_CR28","unstructured":"Food US, Drug A (1997) Review criteria for assessment of rheumatoid factor (Rf) in vitro diagnostic devices using enzyme-linked immunoassay (Eia), enzyme linked immunosorbent assay (Elisa), particle agglutination tests, and laser and rate nephelometry. FDA"},{"issue":"2","key":"3433_CR29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/ar395","volume":"4","author":"MA Boekel Van","year":"2002","unstructured":"Van Boekel MA, Vossenaar ER, Van Den Hoogen FH, Van Venrooij WJ (2002) Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 4(2):87\u201393","journal-title":"Arthritis Res"},{"issue":"6","key":"3433_CR30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1155\/2013\/726598","volume":"35","author":"F Ingegnoli","year":"2013","unstructured":"Ingegnoli F, Castelli R, Gualtierotti R (2013) Rheumatoid factors: clinical applications. Dis Markers 35(6):727\u2013734","journal-title":"Dis Markers"},{"issue":"5","key":"3433_CR31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/ar2786","volume":"11","author":"G Valesini","year":"2009","unstructured":"Valesini G, Alessandri C (2009) Anticitrullinated protein\/peptide antibodies and rheumatoid factors: two distinct autoantibody systems. Arthritis Res Ther 11(5):125. doi: 10.1186\/ar2786","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 2","key":"3433_CR32","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/ar551","volume":"4","author":"G Steiner","year":"2002","unstructured":"Steiner G, Smolen JS (2002) Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res 4(Suppl 2):S1\u2013S5","journal-title":"Arthritis Res"},{"issue":"3","key":"3433_CR33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s002960050069","volume":"18","author":"T Jonsson","year":"1998","unstructured":"Jonsson T, Steinsson K, Jonsson H, Geirsson AJ, Thorsteinsson J, Valdimarsson H (1998) Combined elevation of IgM and IgA rheumatoid factor has high diagnostic specificity for rheumatoid arthritis. Rheumatol Int 18(3):119\u2013122","journal-title":"Rheumatol Int"},{"issue":"1","key":"3433_CR34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, BaW De Jong, Van Den Hoogen FHJ, Hazes JMW, Breedveld FC et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43(1):155\u2013163","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3433_CR35","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/bies.10357","volume":"25","author":"ER Vossenaar","year":"2003","unstructured":"Vossenaar ER, Zendman AJ, Van Venrooij WJ, Pruijn GJ (2003) PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. BioEssays News Rev Mol Cell Dev Biol 25(11):1106\u20131118","journal-title":"BioEssays News Rev Mol Cell Dev Biol"},{"key":"3433_CR36","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/03009740510017689","volume":"24","author":"S Rantap\u00e4\u00e4-Dahlqvist","year":"2005","unstructured":"Rantap\u00e4\u00e4-Dahlqvist S (2005) Diagnostic and prognostic significance of autoantibodies in early rheumatoid arthritis. Scand J Rheumatol 24:83\u201396","journal-title":"Scand J Rheumatol"},{"issue":"11","key":"3433_CR37","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.24827","volume":"61","author":"R Aggarwal","year":"2009","unstructured":"Aggarwal R, Liao K, Nair R, Ringold S, Costenbader KH (2009) Anti-citrullinated peptide antibody (ACPA) assays and their role in the diagnosis of rheumatoid arthritis. Arthritis Rheum 61(11):1472\u20131483","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3433_CR38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.2006.057331","volume":"66","author":"S Rantap\u00e4\u00e4-Dahlqvist","year":"2007","unstructured":"Rantap\u00e4\u00e4-Dahlqvist S, Boman K, Tarkowski A, Hallmans G (2007) Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis. Ann Rheum Dis 66(1):121\u2013123","journal-title":"Ann Rheum Dis"},{"key":"3433_CR39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cca.2014.05.019","volume":"436","author":"M Infantino","year":"2014","unstructured":"Infantino M, Manfredi M, Meacci F, Sarzi-Puttini P, Ricci C, Atzeni F et al (2014) Anti-citrullinated peptide antibodies and rheumatoid factor isotypes in the diagnosis of rheumatoid arthritis: an assessment of combined tests. Clin Chim Acta 436:237\u2013242","journal-title":"Clin Chim Acta"},{"issue":"8","key":"3433_CR40","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3899\/jrheum.111523","volume":"39","author":"YF Hou","year":"2012","unstructured":"Hou YF, Sun GZ, Sun HS, Pan WP, Liu WB, Zhang CQ (2012) Diagnostic value of anti-Sa and anticitrullinated protein antibodies in rheumatoid arthritis. J Rheumatol 39(8):1506\u20131508","journal-title":"J Rheumatol"},{"issue":"2","key":"3433_CR41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/ar1171","volume":"6","author":"HS El-Gabalawy","year":"2004","unstructured":"El-Gabalawy HS, Wilkins JA (2004) Anti-Sa antibodies: prognostic and pathogenetic significance to rheumatoid arthritis. Arthritis Res Ther 6(2):86\u201389","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"3433_CR42","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1172\/JCI119504","volume":"100","author":"K Skriner","year":"1997","unstructured":"Skriner K, Sommergruber WH, Tremmel V, Fischer I, Barta A, Smolen JS et al (1997) Anti-A2\/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex\u2014differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease. J Clin Investig 100(1):127\u2013135","journal-title":"J Clin Investig"},{"issue":"2","key":"3433_CR43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.2008.103283","volume":"69","author":"JJ Luime","year":"2010","unstructured":"Luime JJ, Colin EM, Hazes JMW, Lubberts E (2010) Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review. Ann Rheum Dis 69(2):337\u2013344","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3433_CR44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0049-0172(05)80003-4","volume":"24","author":"IG Otterness","year":"1994","unstructured":"Otterness IG (1994) The value of C-reactive protein measurement in rheumatoid arthritis. Semin Arthritis Rheum 24(2):91\u2013104","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"3433_CR45","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/art.20431","volume":"50","author":"MMJ Nielen","year":"2004","unstructured":"Nielen MMJ, Van Schaardenburg D, Reesink HW, Twisk JWR, Van De Stadt RJ, Van Der Horst-Bruinsma IE et al (2004) Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis. Arthritis Rheum 50(8):2423\u20132427","journal-title":"Arthritis Rheum"},{"issue":"9","key":"3433_CR46","first-page":"2100","volume":"27","author":"J Listing","year":"2000","unstructured":"Listing J, Rau R, Muller B, Alten R, Czerwony G, Gromnica-Ihle E (2000) HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein: independent risk factors of radiographic progression in early rheumatoid arthritis. J Rheumatol 27(9):2100\u20132109","journal-title":"J Rheumatol"},{"issue":"3","key":"3433_CR47","first-page":"414","volume":"35","author":"T Yamane","year":"2008","unstructured":"Yamane T, Hashiramoto A, Tanaka Y, Tsumiyama K, Miura Y, Shiozawa K et al (2008) Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein\/rheumatoid factor. J Rheumatol 35(3):414\u2013420","journal-title":"J Rheumatol"},{"key":"3433_CR48","doi-asserted-by":"crossref","unstructured":"Taylor P, Gartemann J, Hsieh J, Creeden J (2011) A systematic review of serum biomarkers anti-cyclic citrullinated peptide and rheumatoid factor as tests for rheumatoid arthritis. Autoimmune Dis, Article ID 815038.\u00a0doi: 10.4061\/2011\/815038","DOI":"10.4061\/2011\/815038"},{"issue":"5","key":"3433_CR49","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/art.10252","volume":"46","author":"V Saulot","year":"2002","unstructured":"Saulot V, Vittecoq O, Charlionet R, Fardellone P, Lange C, Marvin L et al (2002) Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis. Arthritis Rheum 46(5):1196\u20131201","journal-title":"Arthritis Rheum"},{"issue":"7","key":"3433_CR50","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/art.23596","volume":"58","author":"ML Harris","year":"2008","unstructured":"Harris ML, Darrah E, Lam GK, Bartlett SJ, Giles JT, Grant AV et al (2008) Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis. Arthritis Rheum 58(7):1958\u20131967","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3433-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-016-3433-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3433-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:28:35Z","timestamp":1559028515000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-016-3433-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,9]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["3433"],"URL":"https:\/\/doi.org\/10.1007\/s00296-016-3433-3","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,9]]}}}